Suzanne Buttar

Title: Innovator Spotlight: Suzanne Buttar

Introduction

Suzanne Buttar, based in Cambridge, GB, is a distinguished inventor known for her significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of six patents, she has made strides in developing innovative compounds that serve important therapeutic purposes.

Latest Patents

Among her latest patents, Buttar has developed crystalline forms of 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one. This innovation encompasses various polymorphic forms that offer unique properties for drug formulations. Furthermore, she has disclosed polymorphs of a hydrochloride salt of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one. This patent outlines methods for preparation and utilization, showcasing her commitment to advancing pharmaceutical technologies.

Career Highlights

Suzanne's professional journey includes key roles at prominent companies, including Gilead Calistoga LLC and Cardurion Pharmaceuticals, LLC. Her expertise and innovative mindset have played a crucial role in developing therapeutic solutions that address complex health challenges.

Collaborations

Throughout her career, Buttar has collaborated with esteemed colleagues, including Ernest A. Carra and Tracy Ehiwe. These partnerships underscore the collaborative spirit and innovation-driven environment in which she thrives, contributing to the evolution of new pharmaceutical advancements.

Conclusion

Suzanne Buttar’s journey as an inventor reflects her dedication to innovation and her significant impact on the pharmaceutical industry. With her continuous pursuit of new inventions, she remains a vital contributor to the future of medicine, promising enhanced therapeutic options for various health conditions.